Logo image of T5W.DE

JUST EAT TAKEAWAY (T5W.DE) Stock Fundamental Analysis

FRA:T5W - Deutsche Boerse Ag - NL0012015705 - Common Stock - Currency: EUR

20.12  +0.07 (+0.35%)

Fundamental Rating

3

Taking everything into account, T5W scores 3 out of 10 in our fundamental rating. T5W was compared to 58 industry peers in the Hotels, Restaurants & Leisure industry. T5W scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, T5W is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year T5W has reported negative net income.
In the past year T5W had a positive cash flow from operations.
In the past 5 years T5W always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: T5W reported negative operating cash flow in multiple years.
T5W.DE Yearly Net Income VS EBIT VS OCF VS FCFT5W.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B -5B

1.2 Ratios

Looking at the Return On Assets, with a value of -20.21%, T5W is doing worse than 79.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of -36.91%, T5W is doing worse than 65.52% of the companies in the same industry.
Industry RankSector Rank
ROA -20.21%
ROE -36.91%
ROIC N/A
ROA(3y)-28.03%
ROA(5y)-18.27%
ROE(3y)-46.39%
ROE(5y)-29.77%
ROIC(3y)N/A
ROIC(5y)N/A
T5W.DE Yearly ROA, ROE, ROICT5W.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 48.82%, T5W is in line with its industry, outperforming 51.72% of the companies in the same industry.
In the last couple of years the Gross Margin of T5W has declined.
The Profit Margin and Operating Margin are not available for T5W so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.1%
GM growth 5Y-7.82%
T5W.DE Yearly Profit, Operating, Gross MarginsT5W.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

T5W does not have a ROIC to compare to the WACC, probably because it is not profitable.
T5W has less shares outstanding than it did 1 year ago.
The number of shares outstanding for T5W has been increased compared to 5 years ago.
T5W has a better debt/assets ratio than last year.
T5W.DE Yearly Shares OutstandingT5W.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
T5W.DE Yearly Total Debt VS Total AssetsT5W.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

T5W has an Altman-Z score of -0.64. This is a bad value and indicates that T5W is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.64, T5W is doing worse than 77.59% of the companies in the same industry.
The Debt to FCF ratio of T5W is 13.03, which is on the high side as it means it would take T5W, 13.03 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.03, T5W is in line with its industry, outperforming 41.38% of the companies in the same industry.
T5W has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
T5W has a better Debt to Equity ratio (0.21) than 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 13.03
Altman-Z -0.64
ROIC/WACCN/A
WACC5.44%
T5W.DE Yearly LT Debt VS Equity VS FCFT5W.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

T5W has a Current Ratio of 1.11. This is a normal value and indicates that T5W is financially healthy and should not expect problems in meeting its short term obligations.
T5W has a Current ratio of 1.11. This is in the better half of the industry: T5W outperforms 68.97% of its industry peers.
A Quick Ratio of 1.10 indicates that T5W should not have too much problems paying its short term obligations.
T5W has a Quick ratio of 1.10. This is in the better half of the industry: T5W outperforms 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.1
T5W.DE Yearly Current Assets VS Current LiabilitesT5W.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.54% over the past year.
T5W shows a small growth in Revenue. In the last year, the Revenue has grown by 0.85%.
T5W shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.67% yearly.
EPS 1Y (TTM)7.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.37%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y-7.44%
Revenue growth 5Y53.67%
Sales Q2Q%4.97%

3.2 Future

The Earnings Per Share is expected to grow by 60.72% on average over the next years. This is a very strong growth
T5W is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.97% yearly.
EPS Next Y98.04%
EPS Next 2Y67.44%
EPS Next 3Y48.83%
EPS Next 5Y60.72%
Revenue Next Year-24.01%
Revenue Next 2Y-10.37%
Revenue Next 3Y-6.96%
Revenue Next 5Y6.97%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
T5W.DE Yearly Revenue VS EstimatesT5W.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
T5W.DE Yearly EPS VS EstimatesT5W.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for T5W. In the last year negative earnings were reported.
Also next year T5W is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
T5W.DE Price Earnings VS Forward Price EarningsT5W.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, T5W is valued cheaper than 96.55% of the companies in the same industry.
T5W's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. T5W is more expensive than 60.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.04
EV/EBITDA 2.65
T5W.DE Per share dataT5W.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

T5W's earnings are expected to grow with 48.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.44%
EPS Next 3Y48.83%

0

5. Dividend

5.1 Amount

No dividends for T5W!.
Industry RankSector Rank
Dividend Yield N/A

JUST EAT TAKEAWAY

FRA:T5W (8/4/2025, 7:00:00 PM)

20.12

+0.07 (+0.35%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-30 2025-07-30
Earnings (Next)N/A N/A
Inst Owners51.14%
Inst Owner ChangeN/A
Ins Owners7.56%
Ins Owner ChangeN/A
Market Cap4.20B
Analysts70.4
Price Target20.71 (2.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.51%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.18
P/FCF 35.04
P/OCF 14.96
P/B 0.94
P/tB N/A
EV/EBITDA 2.65
EPS(TTM)-8.13
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.57
FCFY2.85%
OCF(TTM)1.34
OCFY6.68%
SpS17.06
BVpS21.3
TBVpS-3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.21%
ROE -36.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.82%
FCFM 3.37%
ROA(3y)-28.03%
ROA(5y)-18.27%
ROE(3y)-46.39%
ROE(5y)-29.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.1%
GM growth 5Y-7.82%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 13.03
Debt/EBITDA 0.53
Cap/Depr 8.47%
Cap/Sales 4.52%
Interest Coverage N/A
Cash Conversion 16.22%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.1
Altman-Z -0.64
F-Score6
WACC5.44%
ROIC/WACCN/A
Cap/Depr(3y)6.49%
Cap/Depr(5y)15.71%
Cap/Sales(3y)4.14%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.37%
EPS Next Y98.04%
EPS Next 2Y67.44%
EPS Next 3Y48.83%
EPS Next 5Y60.72%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y-7.44%
Revenue growth 5Y53.67%
Sales Q2Q%4.97%
Revenue Next Year-24.01%
Revenue Next 2Y-10.37%
Revenue Next 3Y-6.96%
Revenue Next 5Y6.97%
EBIT growth 1Y16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year217.55%
EBIT Next 3Y51.46%
EBIT Next 5Y39.73%
FCF growth 1Y544.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.8%
OCF growth 3YN/A
OCF growth 5YN/A